Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
Ebselen is an organoselenium drug that inhibits the SARS-CoV-2 main protease (Mpro). Here, the authors co-crystallised Mpro with ebselen and an ebselen derivative and observed an enzyme bound organoselenium covalent adduct in the crystal structures, which was also confirmed by mass spectrometry anal...
Guardado en:
Autores principales: | Kangsa Amporndanai, Xiaoli Meng, Weijuan Shang, Zhenmig Jin, Michael Rogers, Yao Zhao, Zihe Rao, Zhi-Jie Liu, Haitao Yang, Leike Zhang, Paul M. O’Neill, S. Samar Hasnain |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8cf917f0f0d94c58998c45d6d9518f5b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2
por: Ewelina Weglarz-Tomczak, et al.
Publicado: (2021) -
The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation
por: Michael J. Capper, et al.
Publicado: (2018) -
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
por: Alice Douangamath, et al.
Publicado: (2020) -
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Haixia Su, et al.
Publicado: (2021) -
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Wayne Vuong, et al.
Publicado: (2020)